StonvexLoading…
StonvexStonvexStonvexCore line items from ELMD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $64.00M | $54.72M | $48.07M | $41.66M |
Operating Income | $9.66M | $6.58M | $4.01M | $2.97M |
Net Income | $7.54M | $5.15M | $3.17M | $2.31M |
EPS (Diluted) | $0.85 | $0.58 | $0.36 | $0.26 |
Total Assets | $53.80M | $52.23M | $45.81M | $41.36M |
Total Liabilities | $10.59M | $7.69M | $8.14M | $7.19M |
Cash & Equivalents | $15.29M | $16.08M | $7.37M | $8.15M |
Free Cash Flow OCF − CapEx | $11.13M | $8.78M | $-333.00K | $-2.11M |
Shares Outstanding | 8.35M | 8.64M | 8.56M | 8.48M |